We are live on ! Find out more
Mariner

Mariner Portfolio holdings

AUM $95.2B
1-Year Est. Return 32.92%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+32.92%
3 Year Est. Return
+93.86%
5 Year Est. Return
+109.77%
10 Year Est. Return
+319.93%
AUM
$42.2B
AUM Growth
+$4.88B
Cap. Flow
+$1.05B
Cap. Flow %
2.49%
Top 10 Hldgs %
23.7%
Holding
3,248
New
355
Increased
1,579
Reduced
1,041
Closed
206

Sector Composition

Rank Sector Weight
1 Miscellaneous 45.81%
2 Technology 17.1%
3 Financials 7.48%
4 Healthcare 6.31%
5 Consumer Discretionary 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVVD icon
2951
Invivyd
IVVD
$245M
$41.4K ﹤0.01%
10,501
+262
+3% +$496
VEEE icon
2952
Twin Vee PowerCats
VEEE
$5.26M
$41.3K ﹤0.01%
79
TLS icon
2953
Telos
TLS
$316M
$41.2K ﹤0.01%
11,280
-1,370
-11% -$4.55K
GSAT icon
2954
Globalstar
GSAT
$10.6B
$41K ﹤0.01%
1,409
-323
-19% -$7.1K
KG
2955
Kestrel Group
KG
$47.7M
$40.7K ﹤0.01%
889
-129
-13% -$4.78K
INO icon
2956
Inovio Pharmaceuticals
INO
$120M
$39.3K ﹤0.01%
6,429
+88
+1% +$434
FREE
2957
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$38.9K ﹤0.01%
11,410
-2,284
-17% -$7.71K
ACRS icon
2958
Aclaris Therapeutics
ACRS
$814M
$38.5K ﹤0.01%
+36,657
New +$112K
SABA
2959
Saba Capital Income & Opportunities Fund II
SABA
$214M
$38.4K ﹤0.01%
5,063
-15,310
-75% -$120K
SWIM icon
2960
Latham Group
SWIM
$738M
$37.8K ﹤0.01%
+14,365
New +$35.6K
ADVM
2961
DELISTED
Adverum Biotechnologies
ADVM
$37.6K ﹤0.01%
5,000
STLN
2962
Starling Oncology
STLN
$649M
$37.3K ﹤0.01%
18,302
PRQR icon
2963
ProQR Therapeutics
PRQR
$260M
$36.3K ﹤0.01%
18,334
TUP
2964
DELISTED
Tupperware Brands Corporation
TUP
$36.1K ﹤0.01%
18,027
-3,951
-18% -$7.16K
NGD
2965
DELISTED
New Gold Inc
NGD
$35.9K ﹤0.01%
24,621
+9,425
+62% +$11.9K
GERN icon
2966
Geron
GERN
$842M
$35.2K ﹤0.01%
16,668
-678
-4% -$1.32K
VGAS icon
2967
Verde Clean Fuels
VGAS
$28.2M
$34K ﹤0.01%
+14,398
New +$44.3K
DHF
2968
BNY Mellon High Yield Strategies Fund
DHF
$165M
$33.5K ﹤0.01%
14,646
-835
-5% -$1.84K
ME
2969
DELISTED
23andMe Holding Co
ME
$33.5K ﹤0.01%
1,833
-1,862
-50% -$32.2K
CHRS icon
2970
Coherus Oncology
CHRS
$205M
$33.3K ﹤0.01%
+10,000
New +$26.8K
SES icon
2971
SES AI
SES
$229M
$33.1K ﹤0.01%
18,109
+7,390
+69% +$16K
AMRN
2972
Amarin Corp
AMRN
$294M
$32.9K ﹤0.01%
1,893
+809
+75% +$12.7K
AGEN
2973
Agenus
AGEN
$322M
$32.8K ﹤0.01%
+1,980
New +$32.8K
AURE
2974
Aurelion Inc
AURE
$54.5M
$31.5K ﹤0.01%
1,501
PROK icon
2975
ProKidney
PROK
$364M
$31.4K ﹤0.01%
+17,659
New +$37.9K

Similar funds

Mariner's Q4 2023 Portfolio in Review

As of Q4 2023, Mariner held 3,248 positions worth $42.2B, up 13% from $37.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Mariner's Q4 2023 filing shows 355 new, 1,579 increased, 1,041 reduced and 206 closed positions. Its largest new stake was Innovator US Equity Buffer ETF August: 224,881 shares worth $8.09M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $170M.

By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, down from 46% a quarter earlier, followed by Technology and Financials.

  • Mariner's largest Q4 2023 buy was Innovator US Equity Buffer ETF August: 224,881 shares worth $8.09M.
  • Mariner added most to iShares 7-10 Year Treasury Bond ETF in Q4 2023, an estimated $161M increase.
  • Mariner's biggest Q4 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $170M.
  • Mariner fully exited iShares iBonds Dec 2023 Term Corporate ETF in Q4 2023, selling an estimated $26.1M.
  • Mariner's ten largest holdings make up 24% of its $42.2B portfolio in Q4 2023.
  • Mariner opened 355 new positions and closed 206 in Q4 2023.
  • Mariner's portfolio value rose 13% quarter-over-quarter to $42.2B.

Based on Mariner's 13F filing for Q4 2023, filed 14 Feb 2024.